发明名称 |
N-terminally truncated glp-1 derivatives |
摘要 |
The present invention relates to N-terminally truncated derivatives of human glucagon-like peptide-1 (GLP-1) and analogues thereof having a protracted profile of action, as well as the use of such derivatives in pharmaceutical compositions for the treatment of obesity, insulin dependent or non-insulin dependent diabetes mellitus. The GLP-1 derivatives have a lipophilic substituent attached to at least one amino acid residue. |
申请公布号 |
AU2610599(A) |
申请公布日期 |
1999.09.15 |
申请号 |
AU19990026105 |
申请日期 |
1999.02.25 |
申请人 |
NOVO-NORDISK A/S |
发明人 |
LISELOTTE BJERRE KNUDSEN;PER OLAF HUUSFELDT |
分类号 |
C12N15/09;A61K38/00;A61K38/22;A61K38/26;A61K38/28;A61P3/04;A61P3/10;A61P5/50;C07K14/605 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|